Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Permanently Discontinued

PMS-KETOPROFEN E-50 - ECT 50MG

PHARMASCIENCE INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is PMS-KETOPROFEN E-50 - ECT 50MG discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that PMS-KETOPROFEN E-50 - ECT 50MG has been permanently discontinued (last updated November 16, 2021). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is PMS-KETOPROFEN E-50 - ECT 50MG not available?

The reason the manufacturer reported: Business reasons.

Can I still get this?Possibly — same-ingredient product records found
StatusPermanently Discontinued
Same-ingredient products on file2 products · 1 same form & route
Affected strength50MG
Report last updated2021-11-16
Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

⚠ Extended-release and immediate-release formulations are not interchangeable — confirm the release type with your pharmacist before switching.

Other Products

KETOPROFEN SR

Extended-Release

AA PHARMA INC

200MG · DIN 02172577

Different strengthDifferent dosage formSame routeNo current shortage

KETOPROFEN-E

AA PHARMA INC

100MG · DIN 00842664

Different strengthSame dosage formSame routeNo current shortage

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

DIN

02150816

Strength

50MG

Dosage Form

TABLET (ENTERIC-COATED)

Route

ORAL

Active Ingredient

KETOPROFEN

See all KETOPROFEN products →

Product Monograph

Product monograph is not available from Health Canada

View official Health Canada drug record ↗

Shortage History